Search - tctmd.com

Displaying 1 - 20 of 2956

Sort: Relevancy | Date

Presentation

Second Arterial vs Venous Conduits for Multivessel CABG in California

December 20, 2017

Presentation

Meta-analysis of Culprit-only vs Multivessel PCI in Patients With STEMI

December 15, 2017

Presentation

PCI vs CABG in Unprotected Left Main CAD

December 14, 2017

Presentation

Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible ACS

December 14, 2017

Presentation

Nonculprit Stenosis Evaluation Using iFR in Patients With STEMI: iSTEMI Study

December 01, 2017

Presentation

Clinical Outcomes According to FFR or iFR in Deferred Lesions

December 01, 2017

Presentation

TAVR in Pure Native Aortic Valve Regurgitation (AR)

November 30, 2017

Presentation

Impact of Access Site on Outcomes in STEMI Patients Undergoing PCI After Thrombolysis

November 27, 2017

Presentation AHA 2017

Insights from the FOURIER Trial

Presenter: Marc P. Bonaca

November 15, 2017

Presentation AHA 2017

Cost Impact of Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial

Presenter: Andre Lamy

November 15, 2017

Presentation AHA 2017

Impact of Regionalization of ST Elevation Myocardial Infarction Care

Presenter: James G. Jollis

November 14, 2017

Presentation AHA 2017

Time at Blood Pressure Target and the Risk of Cardiovascular Diseases and Mortality

Presenter: Mar Pujades-Rodriguez

November 14, 2017

Presentation AHA 2017

The POISE-2 PCI Substudy

Presenter: Michelle M. Graham

November 14, 2017

Presentation AHA 2017

Subgroup Analysis from the RE-DUAL PCI Trial

Presenter: Jonas Oldgren

November 14, 2017

Presentation AHA 2017

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program

Presenter: Kenneth W. Mahaffey

November 14, 2017

Presentation AHA 2017

Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes

Presenter: Louise Bowman

November 14, 2017

Presentation AHA 2017

Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

Presenter: Steven Weisbord

November 13, 2017

Presentation AHA 2017

Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial

Presenter: Akihiko Nogami

November 13, 2017

Presentation AHA 2017

One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study

Presenter: Zuzana Motovska

November 11, 2017

Presentation Cardiovascular Interventions 2017

Current Status of the Bioresorbable Vascular Scaffold: Where the Data is Leading Us

Presenter: David G. Rizik

November 10, 2017

Advertisement

Second Arterial vs Venous Conduits for Multivessel CABG in California

Meta-analysis of Culprit-only vs Multivessel PCI in Patients With STEMI

PCI vs CABG in Unprotected Left Main CAD

Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible ACS

Nonculprit Stenosis Evaluation Using iFR in Patients With STEMI: iSTEMI Study

Clinical Outcomes According to FFR or iFR in Deferred Lesions

TAVR in Pure Native Aortic Valve Regurgitation (AR)

Impact of Access Site on Outcomes in STEMI Patients Undergoing PCI After Thrombolysis

Insights from the FOURIER Trial

Cost Impact of Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial

Impact of Regionalization of ST Elevation Myocardial Infarction Care

Time at Blood Pressure Target and the Risk of Cardiovascular Diseases and Mortality

The POISE-2 PCI Substudy

Subgroup Analysis from the RE-DUAL PCI Trial

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program

Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes

Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial

One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study

Current Status of the Bioresorbable Vascular Scaffold: Where the Data is Leading Us

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content